Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway
- PMID: 31032525
- DOI: 10.1007/s10637-019-00772-w
Correction to: Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway
Abstract
The authors would like to note an omission of disclosure in this paper. Author JDS is cofounder, equity-holder, and consultant of GILTRx Therapeutics.
Erratum for
-
Sphingadienes show therapeutic efficacy in neuroblastoma in vitro and in vivo by targeting the AKT signaling pathway.Invest New Drugs. 2018 Oct;36(5):743-754. doi: 10.1007/s10637-017-0558-5. Epub 2018 Jan 16. Invest New Drugs. 2018. PMID: 29335887 Free PMC article.
Publication types
LinkOut - more resources
Full Text Sources
